AGC Biologics , a leading global biopharmaceutical contract developer and manufacturer (CDMO), today announced the completion of facility expansion for its new plasmid DNA (pDNA) and messenger RNA (mRNA) production line ) at the CDMO location in Heidelberg, Germany.

With this expansion and additional production line, AGC Biologics is now able to offer more high quality and GMP grade plasmid material and expand its mRNA service offering. The Heidelberg facility expansion leverages state-of-the-art single-use facilities, enabling AGC Biologics to produce multiple projects simultaneously in less time and with faster project turnover - thereby serving more developers requiring pDNA and mRNA materials.

The new facility includes optimized personnel and material flow, new clean rooms for fermentation, chromatography, laminar flow and API filling, single-use bioreactor technology and increased storage space for managing incoming material. The expansion efforts also included independently operated production units for upstream and downstream pDNA processing, linearization, an mRNA production facility and a bottling facility, helping to ensure compliance, quality and flexibility for each project.

“The new facility in Heidelberg is a remarkable development for this location. We have integrated the latest single-use technology to strengthen our unique offering of plasmid DNA and messenger RNA,” said Dieter Kramer, Site General Manager, AGC Biologics Heidelberg. “This expansion complements our extensive capabilities and enables us to achieve manufacturing scalability and serve more developers with needs for these materials worldwide.”

AGC Biologics acquired the Heidelberg campus in 2016 and has since become the CDMO's European Center of Excellence for Plasmid DNA, thanks to the company's 40 years of experience in microbial fermentation, supporting projects from preclinical to commercial phases. AGC Biologics used this knowledge to establish and expand its global pDNA and mRNA services at this location. Today, AGC Biologics Heidelberg offers comprehensive support services for microbial agents, plasmid materials, starting material for in vitro transcribed mRNA vaccines and raw material for adeno-associated vectors and lentiviral vectors.

To learn more about the AGC Biologics Heidelberg facility, visit www.agcbio.com/facilities/heidelberg .

 

Source:businesswire.com

Report Abuse